-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shisi Pharmaceutical: Foreign Trade Sales Remain Steady
Category:
发布时间：2020-03-17
【概要描述】
On March 16, intravenous infusion products manufactured by Shijiazhuang Sihua Pharmaceutical Co., Ltd. were being loaded onto trucks, destined for overseas markets.
On March 16, intravenous infusion products manufactured by Shijiazhuang Sihua Pharmaceutical Co., Ltd. were being loaded onto trucks, destined for overseas markets.
At a time when the COVID-19 pandemic is spreading globally, timely fulfillment of contracts and stable foreign trade demonstrate the sense of responsibility of a conscientious enterprise. The Foreign Trade Department of Shijiazhuang Sihua Pharmaceutical has proactively responded to the impact of the pandemic by conducting “one-on-one” and “screen-to-screen” communications, ensuring uninterrupted order intake and seamless service delivery, thereby bolstering confidence in cooperation. As a result, foreign trade sales continued to post double-digit growth in the first two months of this year.
“China’s foreign trade demonstrates strong resilience, and the long-term upward trend remains unchanged.” At present, Shijiazhuang Sihua Pharmaceutical is making all-out efforts to secure orders and expand markets, aiming for a strong start to the first quarter in foreign trade sales.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091